West Pharma (NYSE: WST) reported Q1 EPS of $1.98, $0.33 better than the analyst estimate of $1.65. Revenue for the quarter came in at $716.6 million versus the consensus estimate of $691.67 million.

For earnings history and earnings-related data on West Pharma (WST) click here.